APA (7th ed.) Citation

J, v. L., R, W., L, B., H, L., S, K., & E, S. (2026). Patient selection for proton therapy in lung cancer: Nationwide external validation and model update of a prognostic model for 2-year mortality including mean heart dose. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 214, 111257. https://doi.org/10.1016/j.radonc.2025.111257

Chicago Style (17th ed.) Citation

J, van Loon, Wijsman R, Boersma L, Langendijk H, Krol S, and Schuit E. "Patient Selection for Proton Therapy in Lung Cancer: Nationwide External Validation and Model Update of a Prognostic Model for 2-year Mortality Including Mean Heart Dose." Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 214 (2026): 111257. https://doi.org/10.1016/j.radonc.2025.111257.

MLA (9th ed.) Citation

J, van Loon, et al. "Patient Selection for Proton Therapy in Lung Cancer: Nationwide External Validation and Model Update of a Prognostic Model for 2-year Mortality Including Mean Heart Dose." Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 214, 2026, p. 111257, https://doi.org/10.1016/j.radonc.2025.111257.